A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
NCT03950843 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 162
Last updated 2019-05-15
Summary
to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
Conditions
Interventions
- DRUG
-
CKD-825
* Dosage Form: capsule * Dosage: 3 types(low/medium/high dose) * Frequency: QD(once daily) administration
- DRUG
-
Placebo oral capsule
Placebo of CKD-825 * Dosage Form: capsule * Dosage: NA * Frequency: QD administration
Sponsors & Collaborators
-
Chong Kun Dang Pharmaceutical
lead INDUSTRY
Principal Investigators
-
Yaemin Park, M.D, Ph.D · Gachon University Gil Medical Center
-
Yongseog Oh, M.D, Ph.D · The Catholic University of Korea
-
JinBae Kim, M.D, Ph.D · Kyunghee University Hospital
-
Seongwook Han, M.D, Ph.D · Keimyung Universtiy Dongsan Medical Center
-
Jongsung Park, M.D, Ph.D · Dong-A University
-
Yeonggeun On, M.D, Ph.D · Samsung Medical Center
-
Kee-Jun Choi, M.D, Ph.D · Asan Medical Center
-
Sang-Weon Park, M.D, Ph.D · Sejong General Hospital
-
Gyo-Seung Hwang, M.D, Ph.D · Ajou University
-
Moon Hyoung Lee, M.D, Ph.D · Severance Hospital
-
Dong-Gu Shin, M.D, Ph.D · Dong-A University Hospital
-
Nam-Ho Kim, M.D, Ph.D · Wonkwang University Hospital
-
Dae-Kyeong Jun, M.D, Ph.D · Inje University
-
Jun Namgung, M.D, Ph.D · Inje University
-
Daehyeok Kim, M.D, Ph.D · Inha University Hospital
-
Hyung Wook Park, M.D, Ph.D · Chonnam National University Hospital
-
Daein Lee, M.D, Ph.D · Chugbuk National University Hospital
-
Hwan-Cheol Park, M.D, Ph.D · Hanyang University
-
Eue-Keun Choi, M.D, Ph.D · Seoul National University
-
Kyung Suk Lee, M.D, Ph.D · Chonbuk National University Hospital
-
Seon-a Jin, M.D, Ph.D · Chungnam National University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-23
- Primary Completion
- 2021-09-30
- Completion
- 2021-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Cardiovascular Inflammation Reduction Trial
NCT01594333 ·Status: COMPLETED ·Phase: PHASE3
-
Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention
NCT04999293 ·Status: COMPLETED
-
Study of LC23-1306 in Healthy Male Subjects
NCT01526577 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
NCT03254446 ·Status: UNKNOWN ·Phase: PHASE3
-
Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease
NCT03718559 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes
NCT00703482 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis
NCT00851500 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea
NCT03524963 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention
NCT00938522 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
NCT05540587 ·Status: RECRUITING ·Phase: PHASE2
-
Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)
NCT01346865 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease
NCT04206176 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
NCT02298088 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
NCT02284048 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
NCT01058018 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
NCT04848220 ·Status: TERMINATED ·Phase: PHASE2
-
Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation
NCT03187197 ·Status: COMPLETED
-
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
NCT03248401 ·Status: COMPLETED ·Phase: PHASE4
-
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
NCT03384966 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran
NCT01595854 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
NCT07050134 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
CER-001 Atherosclerosis Regression ACS Trial
NCT02484378 ·Status: COMPLETED ·Phase: PHASE2
-
Sonodynamic Therapy in the Treatment of Carotid Atherosclerosis
NCT03871725 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Ginkgo Biloba Pills and Placebo in the Treatment of Coronary Heart Disease With Impaired Glucose Regulation
NCT03483779 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)
NCT00132912 ·Status: COMPLETED ·Phase: PHASE2